medicines which are substrates in the CYP3A enzyme as they may come to be considerably less helpful all through treatment with JOURNAVX. Your Health care supplier may have to regulate the dose within your medicine when starting or stopping JOURNAVXEarly investigations into conolidine’s analgesic properties have been carried out in animal products